Peptide · Development · API
PPMO
WuXi TIDES’s peptide platform offers comprehensive CRDMO from drug discovery to commercial manufacturing for both drug substance and drug product.
End to End CRDMO Platform for Drugs
WuXi TIDES’s peptide platform offers comprehensive CRDMO from drug discovery to commercial manufacturing for both drug substance and drug product.
Our peptide discovery synthesis service platform provides high throughput library synthesis and custom synthesis. We support all types of peptides, including linear, cyclic and highly modified peptides, and UAA, linkers, toxins and peptide conjugates. Additionally, we provide dedicated analytical support for all required tests, including unique enantiomeric analysis.
We can seamlessly scale up to any scale to meet various demands from preclinical, clinical to commercial stages with ample capacities and proven capabilities with commercial success. The total reactor volume for Solid Phase Peptide Synthesis (SPPS) is over 100,000 L.
Beyond chemistry, we provide formulation development and manufacturing services with various oral and injectable dosage forms and filling formats. These services are coupled with comprehensive analytical support for both drug substance and drug product under one quality system, as well as the integrated CMC dossier preparation services, enabling our customers to bring their peptide therapeutics to market faster.
Peptide CRDMO Chemistry Platform
from Discovery to Development and Commercial Manufacturing
Unnatural Amino Acid
- α,β,γ-substituted
- N-alkylated
- Glycosylation
- Long Linear
- Cyclic
- Modified
- PEGylated
- Peptidomimetics
Conjugate
- Peptide-PMO (PPMO)
- Peptide-Oligonucleotide (POC)
- Peptide-Drug (PDC)
- Radionuclide Drug (RDC)
Services and Solutions
Discovery Synthesis
Development & Manufacturing
Why WuXi TIDES
What this platform adds
Scalability
From discovery to commercialisation entirely within WuXi TIDES, with readily available large R&D and manufacturing capacity.
Conjugation Chemistry
Seamless collaboration across the oligonucleotide, peptide and small molecule teams — the conjugates nobody else wants to touch.
New Technology
Biocatalysis for gRNA synthesis, thin film evaporation, reactor-in-series with PAT, continuous flow chromatography, TFF.
Global Quality Standard
One quality system across every site, approved by the major regulatory agencies around the world.
Comprehensive Analytical
Method development and validation, IPC and release testing, characterisation and stability under one roof.
Integrated CMC
API and formulation development, manufacturing, analytical, dossier preparation and clinical supply as a single programme.
Meeting global quality standards
Inspection record
How can we help?
Our TIDES drug experts stand ready.
Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.
Small molecule projects? WuXi STA